219
Articles
5.7K
Citations
3.7
avg. Impact Factor
38
h-index

Most Cited Articles of Department of Medicine

TitleJournalYearCitations
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialCirculation2011872
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trialStroke2012333
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escapeImmunological Reviews2008325
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trialCirculation2009299
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Circulation2015179
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyCirculation2013166
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase geneProceedings of the National Academy of Sciences of the United States of America2003161
Adverse childhood experiences and frequent headaches in adultsHeadache2010141
Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic eventsStroke2010140
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillationCirculation2010138
Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in CancerInternational Review of Cell and Molecular Biology2018125
Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trialCirculation2012108
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic SynergismCirculation: Arrhythmia and Electrophysiology2015106
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Journal of the American Heart Association2018104
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryCirculation201399
The T - T interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysisHeart Rhythm201790
J-wave syndromes: Brugada and early repolarization syndromesHeart Rhythm201590
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitorsOncologist201386
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)American Heart Journal201480
Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelinesJAMA Internal Medicine201480
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillationJournal of the American Heart Association201376
HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cellsCancer Research201472
Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective studyHeart Rhythm200969
Esomeprazole induces upper gastrointestinal tract transmucosal permeability increaseAlimentary Pharmacology and Therapeutics200868
Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235Journal of Nuclear Medicine201664